Public Health Vaccines LLC
🇺🇸United States
Clinical Trials
3
Active:0
Completed:3
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)Study to Evaluate the Recombinant VSV (rVSV)-Marburg Virus Vaccine Candidate (PHV01) in Healthy Adult Subjects
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2025-09-05
- Lead Sponsor
- Public Health Vaccines LLC
- Target Recruit Count
- 36
- Registration Number
- NCT06265012
- Locations
- 🇺🇸
CenExel RCA, Hollywood, Florida, United States
Study to Evaluate Safety and Immunogenicity of a Prime-Boost Regimen of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects
Phase 1
Completed
- Conditions
- Nipah Virus Infection
- Interventions
- Biological: Lactated Ringer's
- First Posted Date
- 2024-01-24
- Last Posted Date
- 2025-06-08
- Lead Sponsor
- Public Health Vaccines LLC
- Target Recruit Count
- 120
- Registration Number
- NCT06221813
- Locations
- 🇺🇸
Cenexel ACT (Anaheim Clinical Trials), Anaheim, California, United States
🇺🇸Cenexel RCA (Research Centers of America), Hollywood, Florida, United States
🇺🇸Cenexel JBR (JBR Clinical Research), Salt Lake City, Utah, United States
A Phase 1 Study to Evaluate Safety & Immunogenicity of RVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects
- First Posted Date
- 2022-01-05
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Public Health Vaccines LLC
- Target Recruit Count
- 60
- Registration Number
- NCT05178901
- Locations
- 🇺🇸
Johnson County Clin-Trials(JCCT), Lenexa, Kansas, United States
News
No news found